Typicality: | 0.325 |
Saliency: | 0.176 |
to assess safety | 2 | purpose |
trial → be designed to evaluate → immunogenicity | 5 |
trial → be designed to assess → immunogenicity | 4 |
negative | neutral | positive |
0.100 | 0.825 | 0.075 |
Raw frequency | 9 |
Normalized frequency | 0.176 |
Modifier score | 0.500 |
Perplexity | 65.793 |